|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
51934129
在线人数 :
924
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"taiwan gastrointestinal diseas"的相关文件
显示项目 66-71 / 71 (共2页) << < 1 2 每页显示[10|25|50]项目
| 臺大學術典藏 |
2020-11-02T02:04:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:09Z |
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wu C.-Y.; Liou J.-M.; MING-SHIANG WU; Lin J.-T.; Ho H.J.; Lee C.-C.; Hsu C.-C.; Yeo Y.H. |
| 臺大學術典藏 |
2020-11-02T02:04:03Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; El-Omar E.M.; Chuang E.Y.; Lu T.-P.; Lin J.-T.; Wu J.-Y.; Chen Y.-N.; Hsu W.-F.; Chen C.-Y.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Chen C.-C.; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J. |
| 臺大學術典藏 |
2019 |
From germ theory to germ therapy
|
Chen C.-C.; Chen Y.-N.; Liou J.-M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2019 |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wu M.-S.; El-Omar E.M.; Liou J.-M.;Chen C.-C.;Chang C.-M.;Fang Y.-J.;Bair M.-J.;Chen P.-Y.;Chang C.-Y.;Hsu Y.-C.;Chen M.-J.;Chen C.-C.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Chen C.-Y.;Hsu W.-F.;Chen Y.-N.;Wu J.-Y.;Lin J.-T.;Tzu-Pin Lu;Chuang E.Y.;El-Omar E.M.;Wu M.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; TZU-PIN LU; Chuang E.Y. |
| 國家衛生研究院 |
2018-08-31 |
Systematic review with network meta-analysis: Effectiveness of therapies for second-line helicobacter pylori eradication
|
Yeo, YH;Hsu, CC;Lee, CC;Ho, HJ;Lin, JT;Wu, MS;Liou, JM;Wu, CY;Taiwan Gastrointestinal Disease and Helicobacter Consortium |
显示项目 66-71 / 71 (共2页) << < 1 2 每页显示[10|25|50]项目
|